Documento completo  |  Capítulo completo  |  Expandir índice  |  Versión HTML imprimible
First-Year Experiences with the Interagency Guidelines for Drug Donations
(2000; 51 pages)
Índice de contenido
Ver el documentoAcknowledgements
Ver el documentoExecutive summary
Abrir esta carpeta y ver su contenido1. Introduction
Abrir esta carpeta y ver su contenido2. Sources of information and study methodology
Abrir esta carpeta y ver su contenido3. Dissemination and uptake of the Guidelines
Abrir esta carpeta y ver su contenido4. Basic characteristics of drug donations
Abrir esta carpeta y ver su contenido5. Practical benefits as a result of the Guidelines
Ver el documento6. Drug donations which were hampered, delayed or cancelled
Abrir esta carpeta y ver su contenido7. Experiences and opinions regarding the 12-month shelf-life requirement
Abrir esta carpeta y ver su contenido8. Other suggestions to improve the Guidelines
Abrir esta carpeta y ver su contenido9. How could donation practice be further improved?
Ver el documento10. Summary of recommendations
Ver el documento11. Postscript
Ver el documentoReferences
 

First-Year Experiences with the Interagency Guidelines for Drug Donations

WHO/EDM/PAR/2000.1
English only
Distribution: limited

Department of Essential Drugs and Medicines Policy
World Health Organization

Authors

Ms Radha Asher
Dr Robin Gray
Dr Hans Hogerzeil

Department of Essential Drugs and Medicines Policy
World Health Organization, Geneva

Quotation from an individual health institution:

We see the Guidelines as a help to us, to continue to provide essential services to as many patients as possible, and at reasonable cost. We also see the Guidelines as a necessary component in the development of a health care system that is sustainable, encouraging recipients and patients to take more responsibility in the management of health care delivery.

© World Health Organization 2000
________________________________________
This document is not issued to the general public, and all rights are reserved by the World Health Organization (WHO).
The document may not be reviewed, abstracted, quoted, reproduced or translated, in part or in whole, without the prior written permission of WHO. No part of this document may be stored in a retrieval system or transmitted in any form or by any means - electronic, mechanical or other - without the prior permission of WHO.

The views expressed in documents by named authors are solely the responsibility of those authors.

Ir a la siguiente sección
 
 
El Portal de Información - Medicamentos Esenciales y Productos de Salud de la OMS fue diseñado y es mantenido por la ONG Human Info. Última actualización: le 1 diciembre 2019